Background: ELAFIN (peptidase inhibitor 3, PI3) is an endogenous inhibitor of neutrophil elastase and proteinase 3, but its circulating profile in type 2 diabetes mellitus (T2DM) and cardiovascular disease remains poorly characterized. We investigated circulating ELAFIN in patients undergoing elective coronary angiogra...
B. Krasińska, T. Urbanowicz, M. Kang et al.· Antioxidants· 0 citations
Background: Cardiovascular hemodynamic stress may be associated with alterations in the circulating ionome. We investigated whether a hypothesis-driven multielement composite, the congestion-associated ionomic dysregulation score (CIDS; higher copper and strontium and lower rubidium and iron), was associated with N-ter...
M. Kang, Siwon Baek, G. Raffa et al.· Molecules· 0 citations
Patients with a higher thromboembolic risk gain the most benefits from concomitant SA, with patients at higher thromboembolic risk gaining the most benefits from concomitant SA.
Mariusz Kowalewski, G. Raffa, Jakub Batko et al.· Innovations· 0 citations
Current evidence supports a shift from generalized antioxidant supplementation toward mechanism-matched intervention in biologically selected patients, with the greatest credibility achieved when the active molecular species, dominant mechanism, cardiovascular phenotype, disease stage, clinically relevant exposure, mol...
Siwon Baek, M. Kang, G. Raffa et al.· Antioxidants· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.